Evolent Health, Inc. (EVH) Downgraded to Hold by Truist Securities

Market Context

Evolent Health, Inc. operates in the Healthcare sector. The stock currently trades at $5.51 with a market capitalization of $453.4M.

Analyst downgrades can weigh on a stock in the short term as institutional investors who follow Truist Securities's research adjust their positions. However, downgrades also sometimes create buying opportunities if the market overreacts to the rating change. The reasoning behind the downgrade matters more than the rating itself.

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for Evolent Health, Inc.

Among the 10 most recent ratings: 8 Buy, 2 Hold, 0 Sell.

Date	Firm	Rating	Price Target
Jun 30, 2026	Truist Securities	Hold	N/A
Jun 12, 2026	Truist Securities	Buy	N/A
May 15, 2026	Citigroup	Buy	N/A
May 12, 2026	Canaccord Genuity	Buy	N/A
May 07, 2026	Needham	Buy	N/A

Related Tools: Analyst Ratings Dashboard | View EVH Stock Page